ATOSSA THERAPEUTICS, INC. (ATOS) Free cash flow 2018–2025
ATOSSA THERAPEUTICS, INC. (ATOS) annual free cash flow history — operating cash flow minus capital expenditures, per SEC filings.
-$29.8MFY2025 · since FY2018: -$9.1M → -$29.8M
| Fiscal year | Value | YoY |
|---|---|---|
| FY2025 | -$29.8M | -41.5% |
| FY2024 | -$21.0M | -0.4% |
| FY2023 | -$21.0M | -0.8% |
| FY2022 | -$20.8M | -26.1% |
| FY2021 | -$16.5M | -42.3% |
| FY2020 | -$11.6M | -26.7% |
| FY2019 | -$9.1M | -0.7% |
| FY2018 | -$9.1M | — |
Free cash flow = reported operating cash flow − reported capital expenditures for the same fiscal year.
Source: SEC XBRL filings · For reference only · Not investment advice
More ATOS financial trends
ATOS RevenueATOS Net incomeATOS Net marginATOS Gross profitATOS Gross marginATOS Operating incomeATOS Operating marginATOS Operating cash flowATOS Capital expendituresATOS Return on equityATOS Stock buybacksATOS Dividends paidATOS Total assetsATOS Total liabilitiesATOS Shareholders’ equityATOS overview →